Built to Keep People Enrolled: Why the Cure Era Needs a Measurement Layer

Something strange is happening in mental health. The science is racing toward the cure, with rapid-acting treatments, neuromodulation, and a new generation of therapeutics that aim at remission instead of lifelong management. And yet the system those treatments arrive into is quietly built to do the opposite of cure. It is built to keep people enrolled.

That isn’t a conspiracy. No one drew up a plan to keep patients sick. It’s just what you get when you pay for activity instead of outcomes, visit by visit, login by login, month by month. The result is a behavioral health economy that runs beautifully whether or not anyone actually gets well. If we want the cure era to land, that is the part we have to redesign.

The incentive nobody designed on purpose

Walk the money backward and the pattern is obvious. Fee-for-service pays the clinician for the encounter, not the recovery. A fifth session bills the same whether the patient is thriving or stuck. The consumer mental-health app economy is worse: many of those products are valued on daily active users and time-in-app, which means a patient who gets better and stops opening the app reads, on a dashboard somewhere, as churn.

So the entire stack of providers, platforms, and payers is optimized for retention. Engagement becomes the proxy for value because engagement is the thing we can count. We’ve ended up measuring how long people stay in treatment because we never built a good way to measure whether treatment worked.

This is the real barrier to the cure era, and it’s worth being clear-eyed that the barrier is no longer primarily scientific. Pharma and device makers are now making genuinely curative bets, wagering real capital that depression can be sent into durable remission. That’s the good side of this story. The drag is on the delivery and payment side, where the scoreboard still rewards keeping the lights on rather than turning the corner.

Value-based behavioral health flips the scoreboard

The fix is already taking shape, and it’s a hopeful one. Value-based behavioral health changes the unit of payment from the visit to the result. You get paid when the patient gets better, and stays better.

Policy is moving in exactly this direction. The CMS Innovation in Behavioral Health (IBH) Model put behavioral health providers at the center of value-based, integrated care across four state Medicaid programs in an eight-year demonstration that began in January 2025. And the CMS ACCESS Model’s behavioral health track, launching in July 2026, ties recurring payments to outcomes for depression and anxiety, tracked with standardized PHQ-9 and GAD-7 scores over a 12-month episode. (We wrote about what that payment shift means for practices in our look at the CMS ACCESS model.) Commercial payers are following with enhanced rates for collaborative care and outcome-based contracts.

The thesis underneath all of it is simple: stop paying for retention, start paying for recovery. When you do, every incentive that used to pull against the cure starts pulling toward it. A patient who reaches remission and discharges becomes the win, not the lost revenue.

But you can’t pay for recovery you can’t measure

Here’s the catch, and it’s the whole reason this series exists. Value-based care is a promise to pay for outcomes, but mental health is still the one field of medicine that treats and bills largely on “how have you been feeling?” You cannot write an outcomes contract against a number you don’t reliably collect.

And today, we mostly don’t collect it. Fewer than 20% of behavioral health clinicians consistently practice measurement-based care, even though most of them believe it sharpens decisions and strengthens the alliance with their patients. The barrier they cite isn’t skepticism. It’s friction: the tools don’t fit into the visit, the data lives in a dozen disconnected places, and capturing it steals time they don’t have. (That gap between knowing and measuring is the one we explored in what clinicians miss when they only ask.)

This is why measurement isn’t a nice-to-have inside value-based behavioral health. It’s the load-bearing wall. A 5-day remission claim, a value-based contract, an outcomes guarantee: none of them mean anything without continuous, objective, between-visit signal to verify that recovery actually happened and actually held. The cure era and the measurement layer aren’t two trends. They’re the same trend.

What changes when recovery is the unit of value

Picture the practice on the other side of this shift. Clinicians spend their attention where it moves the needle, because they can see, early and clearly, who is responding and who isn’t, instead of discovering a non-response three months and twelve sessions too late. Payers fund what works and stop funding what doesn’t, which frees up capacity in a workforce that is already stretched far past its limits. And patients become the point again: the goal is to get them well and send them back to their lives, not to keep them on the books.

That future is genuinely good for everyone who chose this field to help people recover. It just requires us to be honest that recovery has to be measured to be paid for, and measured well enough that a clinician trusts it, a payer will write a check against it, and a patient can feel it in their own life.

The shift is not theoretical. At BHSN, a community behavioral health network, continuous between-visit measurement gave clinicians an early, objective read on who was responding and who wasn’t, rather than waiting for the next scheduled visit to find out. That visibility helped the team act sooner and contributed to a 64% reduction in crisis alerts and a 50% improvement in PHQ-9 and GAD-7 scores within 14 days, while freeing up more than 1,500 staff hours. Those are the kinds of numbers a payer can underwrite: not how often a patient logged in, but whether they actually got better, and how fast.

The cure era is coming whether or not the system is ready for it. The organizations that win it will be the ones that can prove recovery, not just bill for retention. That proof starts with measurement.